Philip_Cholesterol Metabolism BCC
Learning Objectives
Recognize the chemical structure of cholesterol and identify basic building blocks.
Describe sources of cholesterol:
Dietary intake: eggs, beef, poultry, cheese.
De novo synthesis: liver, extrahepatic tissues.
Define physiological significance and role of cholesterol:
Crucial for cell membranes, bile salts, steroid hormones, vitamin D.
Excessive levels linked to heart disease.
List the 4 steps of cholesterol biosynthesis.
Explain regulation of cholesterol synthesis.
Define mechanism of statins and relevant clinical pearls.
List three main uses of synthesized cholesterol.
Discuss role of bile acids, biliary cholesterol, and cholesterol esters.
Describe common biological molecules cholesterol esters are precursors for.
Explain LDL metabolism and target drug therapies.
Physiological Roles of Cholesterol
Cell Membranes: Essential component, only found in animal cells.
Precursors:
Bile Salts: Aid in fat digestion.
Steroid Hormones: Include sex hormones, adrenal hormones.
Vitamin D: Synthesized from cholesterol.
Lipoproteins: Major component for lipid transport.
Health Implications: High cholesterol levels lead to heart disease.
Cholesterol Structure
Composition:
Steroid Nucleus: 4 hydrocarbon rings.
Branch Chain: Hydrocarbon chain attached to the D ring.
Details:
27 carbon atoms.
Hydroxyl group at C3.
Double bond between C5 and C6.
Highly non-polar.
Sources of Cholesterol
Dietary Intake: Found in animal products (e.g., eggs, meat).
De Novo Synthesis: Primarily in the liver.
Other Tissues: Synthesis in extrahipatic tissues.
Cholesterol Synthesis
Location: Cytoplasm or endoplasmic reticulum.
Energy Source: Hydrolysis of ATP and acetyl-CoA.
Carbon Source: All 27 carbons from acetyl-CoA.
Production: NADPH provides reducing power, with acetyl-CoA converted to citrate in mitochondria, then cleaved back to acetyl-CoA in the cytosol.
Cholesterol Synthesis Stages
Stage 1: Acetyl CoA --> HMG-CoA.
Key Enzyme: HMG-CoA reductase (rate-limiting step).
Feedback inhibitors: Cholesterol and mevalonate.
Completion: Transition through multiple stages, with squalene being a key intermediate leading to cholesterol.
Regulation of Cholesterol Synthesis
Key Regulator: HMG-CoA reductase.
Regulation Mechanisms:
Gene transcription and new protein synthesis.
Protein degradation via proteolysis.
Covalent modification (phosphorylation by AMPK).
Competitive inhibition (statins).
Regulation by Phosphorylation
Glucagon Activation: Increases AMPK activity leading to HMG-CoA reductase inactivation.
Insulin Activation: Promotes protein phosphatase that dephosphorylates and activates HMG-CoA reductase.
Regulation by Competitive Inhibition
Statins: Competitive inhibitors of HMG-CoA reductase; limit cholesterol synthesis, used for hypercholesterolemia.
Coenzyme Q10 Impact: Statin usage may decrease levels; supplements considered.
Cholesterol Metabolism Products
Secreted by Hepatocytes:
Cholesterol esters
Biliary cholesterol
Bile acids
Bile Acids
Formation: Synthesized from cholesterol in the liver; stored in the gallbladder for lipid digestion.
Characteristics: Amphipathic nature aids in emulsifying lipids in intestines.
Bile Salts and Biliary Cholesterol
Conjugation: Bile acids combined with amino acids for excretion.
Efficacy: More effective for cholesterol excretion than bile acids.
Cholesterol Esters
Nature: Majority of cholesterol exists as esters; attached long-chain fatty acid increases hydrophobicity.
Function: Not part of membranes; transport form packaged into lipoproteins (VLDL, LDL) for tissue delivery.
Steroid Hormones
Source: All classes of steroid hormones are cholesterol-derived.
Synthesis Locations: Adrenal cortex, gonads, placenta.
Vitamin D
Sources: Obtained through dietary means or synthesized from cholesterol precursors.
VLDL Metabolism
Production: Synthesized in liver.
Transport Role: Delivers triglycerides (TAGs) to tissues.
Hydrolysis: Lipoprotein lipase hydrolyzes TAGs into fatty acids and glycerol.
Conversion: Remnants can form IDL or be converted to LDL.
LDL Metabolism
Binding Mechanism: LDL binds to specific receptors, followed by endocytosis.
Degradation Products: Free cholesterol, fatty acids, amino acids, phospholipids.
PCSK9 Role: Binds to LDL receptors, increasing degradation of receptors; inhibitors allow more receptors to clear LDL from bloodstream (e.g., Alirocumab, Evolocumab).